5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection
The FDAapproved tesamorelin dose is 2 mg SC daily [3] , while ipamorelin is commonly studied at 100300 mcg SC daily [4]
By choosing a compounded tirzepatide solution, youre opting for a high level of customization that can help maximize the benefits of peptide therapy
Comprehensive and Tailored Care to Start Your Journey The process begins with a comprehensive intake appointment where we gather essential information to understand your health, lifestyle, and weight loss goals
These approaches serve different research purposes and are not mutually exclusive